Investments in Unconsolidated Entities - Schedule of Financial Statements For The Investment in Unconsolidated Equity (Details) - USD ($) $ in Thousands	5 Months Ended	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Operating revenues		$ 5,273,309	$ 6,908,923	$ 7,497,689
Net income		242,115	1,734,544	1,780,942
Current assets	$ 1,714,679	1,714,679	2,012,975
Total assets	39,830,255	39,830,255	25,285,098	22,669,926
Current liabilities	2,461,549	2,461,549	2,036,840
Total liabilities	15,552,119	15,552,119	10,504,281
Members' equity	24,278,136	24,278,136	14,780,817	$ 11,213,328	$ 9,970,999
Total liabilities and equity	39,830,255	39,830,255	$ 25,285,098
MVP Joint Venture
Schedule of Equity Method Investments [Line Items]
Operating revenues	247,360
Operating income	126,202
Net income	129,773
Current assets	204,028	204,028
Noncurrent assets	9,535,975	9,535,975
Total assets	9,740,003	9,740,003
Current liabilities	69,303	69,303
Noncurrent liabilities	1,514	1,514
Total liabilities	70,817	70,817
Members' equity	9,669,186	9,669,186
Total liabilities and equity	$ 9,740,003	$ 9,740,003